Zhu et al. discovered that kidney diseases can be treated by targeting and regulating CerS6, which alleviates glomerular inflammation and podocyte damage in diabetic mice, and alters glycolipid metabolism [50]. The gene discussed is CERS6; the disease is kidney disorder.